# Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

> **NCT00005581** · PHASE3 · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00005581
- **Lead sponsor:** IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005581, "Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00005581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*